‌

‌
‌

‌
‌
‌

‌
‌
‌
‌
‌
‌

Rainbow Childrens Medicare Stock Price - ₹1,440.80 | Healthcare Services | askfuzz

Rainbow Childrens Medicare

RAINBOW

NSE

BSE

SectorHealthcare Services

Loading chart…

The Quarter story

The two most recent quarterly results, compared side-by-side.

Rainbow Childrens Medicare expands its hospital network and patient volume, but rising costs and debt are squeezing profit margins.

Revenue grew from ₹3,529.3 Cr to ₹4,699.9 Cr from Q1 FY26 to Q1 FY27 — consistent top-line expansion

EBITDA margin contracted from 29.4% to 28.6% from Q1 FY26 to Q1 FY27 — cost pressure on operations

OP consultations rose from 3,29,331 to 4,10,590 from Q1 FY26 to Q1 FY27 — strong outpatient demand

PAT margin fell from 15.2% to 13.3% from Q1 FY26 to Q1 FY27 — margin compression

Hospital count expanded from 20 to 24 from Q1 FY26 to Q1 FY27 — wider geographic reach

Material costs rose from ₹475.0 Cr to ₹645.4 Cr from Q1 FY26 to Q1 FY27 — weighing on gross margins

ARPOB increased from ₹63,323 to ₹67,256 from Q1 FY26 to Q1 FY27 — stronger revenue per bed

Finance costs increased from ₹180.8 Cr to ₹212.1 Cr from Q1 FY26 to Q1 FY27 — higher debt servicing

MF and AIF stake climbed from 13.4% to 19.9% from Q1 FY26 to Q1 FY27 — growing institutional confidence

FPI and NRI stake dropped from 23.7% to 16.0% from Q1 FY26 to Q1 FY27 — foreign investor exit

About the company

Rainbow Children's Medicare Limited is a leading chain of multi-specialty pediatric, obstetrics, and gynecology hospitals in India. Originally incorporated in 1998, it operates 16 hospitals and three clinics across six cities, with a total bed capacity of 1,655. The company specializes in pediatric services, including newborn and pediatric intensive care, multi-specialty services, and quaternary care, as well as obstetrics and gynecology services. Founded by Dr. Ramesh Kancharla, Rainbow follows a full-time, exclusive doctor-led model of healthcare delivery. The company expanded its services over the years, establishing hospitals in various cities and introducing new specialties. In 2022, Rainbow completed an Initial Public Offering and its shares were listed on the National Stock Exchange of India Limited and BSE Limited. The company also offers post-graduate DNB and fellowship programs in pediatrics.

In the news